|
Volumn 45, Issue 6, 2020, Pages 1213-1218
|
Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking
a a a a a a a a a a a a a a |
Author keywords
2019 nCoV; clinical practice and basic research integration; COVID 19; formula screening; molecular docking; traditional Chinese medicine
|
Indexed keywords
ANGIOTENSIN CONVERTING ENZYME 2;
CORONAVIRUS SPIKE GLYCOPROTEIN;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HERBACEOUS AGENT;
SPIKE GLYCOPROTEIN, COVID-19 VIRUS;
BETACORONAVIRUS;
CHEMISTRY;
CHINA;
CHINESE MEDICINE;
CORONAVIRUS DISEASE 2019;
CORONAVIRUS INFECTION;
HUMAN;
MOLECULAR DOCKING;
PANDEMIC;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
VIRUS PNEUMONIA;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BETACORONAVIRUS;
CHINA;
CORONAVIRUS INFECTIONS;
DRUGS, CHINESE HERBAL;
HUMANS;
MEDICINE, CHINESE TRADITIONAL;
MOLECULAR DOCKING SIMULATION;
PANDEMICS;
PEPTIDYL-DIPEPTIDASE A;
PNEUMONIA, VIRAL;
SPIKE GLYCOPROTEIN, CORONAVIRUS;
|
EID: 85082195776
PISSN: 10015302
EISSN: None
Source Type: Journal
DOI: 10.19540/j.cnki.cjcmm.20200206.501 Document Type: Article |
Times cited : (40)
|
References (0)
|